Just because some institutions bought, doesn't mean it's a good investment. Case in point: SAC upped their stake in DNDN right before it blew up.
I'm not a basher, I'm simply pointing out that with a strong patent, AMRN will have a hard time selling AMR101 at a profitable price competing with fish oil processors. After all, they are getting all their trial supplies from a Japanese fish oil processor now so the manufacturing is not that hard at all.
If you disagree, please list your facts. Don't just say "you are a basher".